VT

Velayudhan Thadathil Saji

Active Director Director DIN 10329903
DIN 10329903 First appointment Sep 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Velayudhan Thadathil Saji

Data last updated:

Velayudhan Thadathil Saji is a Director at Kl Therapeutics Private Limited (since 2023). The company operates in Pharma.

DIN 10329903
Primary Designation Director
Industry Pharma
First Appointment 21 Sep 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kl Therapeutics Private Limited U46596KL2023PTC083644
Director21 Sep 20232023Active

Board colleagues of Velayudhan Thadathil Saji

NameDINCompanyDesignation
Mohanan Thadathil Velayudhan10329904Kl Therapeutics Private LimitedDirector

Directorship timeline

Open interactive timeline →
Kl Therapeutics Private Limited
Premium access

Shareholding and investment profile for Velayudhan Thadathil Saji

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Velayudhan Thadathil Saji

Velayudhan Thadathil Saji currently holds 1 directorship: Kl Therapeutics Private Limited (Director, since 21 Sep 2023).

Velayudhan Thadathil Saji was first appointed on 21 Sep 2023 as Director at Kl Therapeutics Private Limited.

The current boards of Velayudhan Thadathil Saji's companies include Mohanan Thadathil Velayudhan (Kl Therapeutics Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available